Financials

  • Market Capitalization 272.35 M
  • Employee 106
  • Founded 2014
  • CEO N/A
  • Website www.zentalis.com
  • Headquarter California, United States
  • FIGI BBG00R2K8TF5
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.71
Relación precio/flujo de caja

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3419
PYXS
Pyxis Oncology, Inc. - Common Stock
3.23 USD-2.71%+4.87%+11.38%+141.04%269.41 M USD
3422
SION
Sionna Therapeutics, Inc. - Common Stock
5.97 USD-1.49%+10.97%-87.25%-84.82%269.92 M USD
3425
SRZN
Surrozen, Inc. - Common Stock
22.43 USD-6.58%-6.50%+14.56%+93.53%263.63 M USD
3436
WHWK
Whitehawk Therapeutics, Inc. - Common Stock
4.63 USD-4.93%-0.43%+25.82%+53.82%263.95 M USD

Noticias